Key result
Primary PCI in nonagenarians with STEMI is linked to ~42% lower in-hospital mortality versus medical management.
Why the study?
Nonagenarians are the fastest-growing age decade in the US, but limited evidence exists regarding trends and treatment outcomes for STEMI in this population.
Does primary percutaneous coronary intervention reduce in-hospital mortality compared to medical management in nonagenarians presenting with STEMI?
Cohort (n=41,042)
Yes
Does primary percutaneous coronary intervention reduce in-hospital mortality compared to medical management in nonagenarians presenting with STEMI?
In nonagenarians presenting with STEMI, primary PCI is associated with significantly lower in-hospital mortality compared to medical management alone, despite higher rates of complications and costs.
Answers are grounded in this paper and cite their sources.
May support primary PCI consideration in selected nonagenarians with STEMI; leaves open confirmation in randomized trials.
OBJECTIVE: To assess ST elevation myocardial infarction (STEMI) trends and outcomes in nonagenarians undergoing primary percutaneous coronary intervention (pPCI) compared to medical management. BACKGROUND: Although nonagenarians (age greater than 90 years) represent the fast-growing age decade of the US population, limited evidence is available regarding trends and outcomes of treatment strategies for STEMI in this population cohort. METHODS: We performed a retrospective analysis using the National Inpatient Sample (NIS) database to identify nonagenarians presenting with STEMI and treated with either pPCI or medical management. In-hospital mortality, in-hospital complications, length of stay and in-hospital costs were analyzed. RESULTS: Between 2010-2017, 41,042 STEMI hospitalizations were identified in nonagenarians, of which 11, 155 (27.2%) included pPCI whereas 29, 887 (72.8%) included medical management. STEMI hospitalizations among nonagenarians decreased over the study period. Overall unadjusted in-hospital mortality was 21.6%, and the hospitalizations that included pPCI had significantly lower mortality compared to the medical management (13.6% vs. 24.5%, p < .001). After adjusting for baseline characteristics, hospitalizations that included pPCI had 42.1% lower odds of in-hospital mortality (adjusted OR: 0.58, 95% CI: 0.50 to 0.67, p < .001). Altogether, in-hospital cardiac, bleeding and vascular complications, length of stay and in-hospital costs were higher in pPCI hospitalizations. CONCLUSION: In nonagenarians, STEMI mortality is high, but pPCI is associated with superior outcomes compared to medical management alone. Therefore, pPCI can be considered an acceptable treatment strategy in this population.
No takes yet. Share an insight, caveat, or question.
Pajjuru et al. (2020) conducted a cohort in ST elevation myocardial infarction (STEMI) (n=41,042). Primary percutaneous coronary intervention (pPCI) vs. Medical management was evaluated on In-hospital mortality (adjusted OR 0.58, 95% CI 0.50 to 0.67, p=< .001). Primary percutaneous coronary intervention in nonagenarians with STEMI was associated with lower in-hospital mortality compared to medical management.
Synapse has enriched 10 related papers. Consider them for comparative context: